196 related articles for article (PubMed ID: 37174980)
1. The Prognostic Effect of CDKN2A/2B Gene Deletions in Pediatric Acute Lymphoblastic Leukemia (ALL): Independent Prognostic Significance in BFM-Based Protocols.
Ampatzidou M; Papadhimitriou SI; Paisiou A; Paterakis G; Tzanoudaki M; Papadakis V; Florentin L; Polychronopoulou S
Diagnostics (Basel); 2023 Apr; 13(9):. PubMed ID: 37174980
[TBL] [Abstract][Full Text] [Related]
2. Copy Number Alteration Profile Provides Additional Prognostic Value for Acute Lymphoblastic Leukemia Patients Treated on BFM Protocols.
Ampatzidou M; Florentin L; Papadakis V; Paterakis G; Tzanoudaki M; Bouzarelou D; Papadhimitriou SI; Polychronopoulou S
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34209196
[TBL] [Abstract][Full Text] [Related]
3. Childhood Acute B-Lineage Lymphoblastic Leukemia With CDKN2A/B Deletion Is a Distinct Entity With Adverse Genetic Features and Poor Clinical Outcomes.
Feng J; Guo Y; Yang W; Zou Y; Zhang L; Chen Y; Zhang Y; Zhu X; Chen X
Front Oncol; 2022; 12():878098. PubMed ID: 35712467
[TBL] [Abstract][Full Text] [Related]
4. Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.
Volejnikova J; Mejstrikova E; Dörge P; Meissner B; Zimmermannova O; Svojgr K; Stanulla M; Cario G; Schrappe M; Stary J; Hrusak O; Trka J; Fronkova E
Pediatr Blood Cancer; 2013 Mar; 60(3):420-7. PubMed ID: 22997141
[TBL] [Abstract][Full Text] [Related]
5. Combination of minimal residual disease on day 15 and copy number alterations results in BCR-ABL1-negative pediatric B-ALL: A powerful tool for prediction of induction failure.
Baghdadi H; Soleimani M; Zavvar M; Bahoush G; Poopak B
Cancer Genet; 2024 Apr; 282-283():27-34. PubMed ID: 38183785
[TBL] [Abstract][Full Text] [Related]
6. Cyclin dependent kinase inhibitor 2A/B gene deletions are markers of poor prognosis in Indian children with acute lymphoblastic leukemia.
Agarwal M; Bakhshi S; Dwivedi SN; Kabra M; Shukla R; Seth R
Pediatr Blood Cancer; 2018 Jun; 65(6):e27001. PubMed ID: 29446543
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of CDKN2A/B deletions in acute lymphoblastic leukaemia: a meta-analysis.
Zhang W; Kuang P; Liu T
Ann Med; 2019 Feb; 51(1):28-40. PubMed ID: 30592434
[TBL] [Abstract][Full Text] [Related]
8. IKZF1
Stanulla M; Dagdan E; Zaliova M; Möricke A; Palmi C; Cazzaniga G; Eckert C; Te Kronnie G; Bourquin JP; Bornhauser B; Koehler R; Bartram CR; Ludwig WD; Bleckmann K; Groeneveld-Krentz S; Schewe D; Junk SV; Hinze L; Klein N; Kratz CP; Biondi A; Borkhardt A; Kulozik A; Muckenthaler MU; Basso G; Valsecchi MG; Izraeli S; Petersen BS; Franke A; Dörge P; Steinemann D; Haas OA; Panzer-Grümayer R; Cavé H; Houlston RS; Cario G; Schrappe M; Zimmermann M; ;
J Clin Oncol; 2018 Apr; 36(12):1240-1249. PubMed ID: 29498923
[TBL] [Abstract][Full Text] [Related]
9. Clinical impacts of copy number variations in B-cell differentiation and cell cycle control genes in pediatric B-cell acute lymphoblastic leukemia: a single centre experience.
Crepinsek K; Marinsek G; Kavcic M; Prelog T; Kitanovski L; Jazbec J; Debeljak M
Radiol Oncol; 2021 Dec; 56(1):92-101. PubMed ID: 34957727
[TBL] [Abstract][Full Text] [Related]
10. Rapid Identification of Key Copy Number Alterations in B- and T-Cell Acute Lymphoblastic Leukemia by Digital Multiplex Ligation-Dependent Probe Amplification.
Thakral D; Kaur G; Gupta R; Benard-Slagter A; Savola S; Kumar I; Anand R; Rani L; Verma P; Joshi S; Kumar L; Sharma A; Bakhshi S; Seth R; Singh V
Front Oncol; 2019; 9():871. PubMed ID: 31572674
[TBL] [Abstract][Full Text] [Related]
11. Deletion of CDKN2A/B is associated with inferior relapse free survival in pediatric B cell acute lymphoblastic leukemia.
Kathiravan M; Singh M; Bhatia P; Trehan A; Varma N; Sachdeva MS; Bansal D; Jain R; Naseem S
Leuk Lymphoma; 2019 Feb; 60(2):433-441. PubMed ID: 29966470
[TBL] [Abstract][Full Text] [Related]
12. Association of
Onizuka M; Kikkawa E; Machida S; Toyosaki M; Suzuki R; Ogiya D; Aoyama Y; Amaki J; Harada K; Hara R; Shiraiwa S; Ogawa Y; Kawada H; Ando K
Blood Cell Ther; 2023 Aug; 6(3):80-86. PubMed ID: 38146355
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of copy number alterations detected by multi-link probe amplification of multiple genes in adult acute lymphoblastic leukemia.
Fang Q; Yuan T; Li Y; Feng J; Gong X; Li Q; Zhao X; Liu K; Tang K; Tian Z; Zhang Q; Wang Y; Liu B; Wang M; Ru K; Wang J; Mi Y
Oncol Lett; 2018 Apr; 15(4):5359-5367. PubMed ID: 29552179
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols.
Ribera J; Morgades M; Zamora L; Montesinos P; Gómez-Seguí I; Pratcorona M; Sarrà J; Guàrdia R; Nomdedeu J; Tormo M; Martínez-Lopez J; Hernández-Rivas JM; González-Campos J; Barba P; Escoda L; Genescà E; Solé F; Millá F; Feliu E; Ribera JM;
Cancer; 2015 Nov; 121(21):3809-17. PubMed ID: 26194343
[TBL] [Abstract][Full Text] [Related]
15. Clinical and Prognostic Impact of Copy Number Alterations and Associated Risk Profiles in a Cohort of Pediatric B-cell Precursor Acute Lymphoblastic Leukemia Cases Treated Under ICiCLe Protocol.
Gupta SK; Singh M; Chandrashekar PH; Bakhshi S; Trehan A; Gupta R; Thakur R; Gajendra S; Sharma P; Sreedharanunni S; Sachdeva MS; Pushpam D; Varma N; Bansal D; Jain R; Peyam S; Moorman AV; Bhatia P
Hemasphere; 2022 Oct; 6(10):e782. PubMed ID: 36204689
[TBL] [Abstract][Full Text] [Related]
16. Copy Number Alterations are Associated with the Risk of Very Early Relapse in Pediatric B-lineage Acute Lymphoblastic Leukemia: A Nested Case-control MIGICCL Study.
Rosales-Rodríguez B; Núñez-Enríquez JC; Velázquez-Wong AC; González-Torres C; Gaytán-Cervantes J; Jiménez-Hernández E; Martín-Trejo JA; Campo-Martínez MLÁD; Medina-Sanson A; Flores-Lujano J; Flores-Villegas LV; Peñaloza-González JG; Torres-Nava JR; Espinosa-Elizondo RM; Amador-Sánchez R; Miranda-Madrazo MR; Santillán-Juárez JD; Pérez-Saldívar ML; Gurrola-Silva A; Orozco-Ruiz D; Solís-Labastida KA; Velázquez-Aviña MM; Duarte-Rodríguez DA; Mata-Rocha M; Sepúlveda-Robles OA; Ortiz-Maganda M; Bekker-Méndez VC; Jiménez-Morales S; Mejía-Aranguré JM; Rosas-Vargas H
Arch Med Res; 2021 May; 52(4):414-422. PubMed ID: 33541741
[TBL] [Abstract][Full Text] [Related]
17. Genomic CDKN2A/2B deletions in adult Ph
Pfeifer H; Raum K; Markovic S; Nowak V; Fey S; Obländer J; Pressler J; Böhm V; Brüggemann M; Wunderle L; Hüttmann A; Wäsch R; Beck J; Stelljes M; Viardot A; Lang F; Hoelzer D; Hofmann WK; Serve H; Weiss C; Goekbuget N; Ottmann OG; Nowak D
Blood; 2018 Mar; 131(13):1464-1475. PubMed ID: 29348129
[TBL] [Abstract][Full Text] [Related]
18. CDKN2A deletions are associated with poor outcomes in 101 adults with T-cell acute lymphoblastic leukemia.
Wang HP; Zhou YL; Huang X; Zhang Y; Qian JJ; Li JH; Li XY; Li CY; Lou YJ; Mai WY; Meng HT; Yu WJ; Tong HY; Jin J; Zhu HH
Am J Hematol; 2021 Mar; 96(3):312-319. PubMed ID: 33306218
[TBL] [Abstract][Full Text] [Related]
19. The Prognostic Effect of
Østergaard A; Enshaei A; Pieters R; Vora A; Horstmann MA; Escherich G; Johansson B; Heyman M; Schmiegelow K; Hoogerbrugge PM; den Boer ML; Kuiper RP; Moorman AV; Boer JM; van Leeuwen FN
Hemasphere; 2023 May; 7(5):e875. PubMed ID: 37153875
[No Abstract] [Full Text] [Related]
20. Prognostic significance of IKZF1 deletions and IKZF1
Braun M; Pastorczak A; Sędek Ł; Taha J; Madzio J; Jatczak-Pawlik I; Wypyszczak K; Matysiak M; Derwich K; Lejman M; Kazanowska B; Szczepański T; Kowalczyk JR; Mlynarski W;
Hematol Oncol; 2022 Aug; 40(3):430-441. PubMed ID: 35118711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
